Showing results (61-70 of 276) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastasesFlorian Heitz, Philipp Harter, Hans-Joachim Lueck, et al.
Gynecologic Oncology|November 20, 2016
Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancerFlorian Heitz, Alexandra Hengsbach, Philipp Harter, et al.
Gynecologic Oncology|March 19, 2011
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancerPhilipp Harter, Zelal M Muallem, Christine Buhrmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR GermanyJacobus Pfisterer, Andreas Du Bois, Eva-Katrin Bentz, et al.
Archives of Gynecology and Obstetrics|May 21, 2015
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancerChristina Fotopoulou, Ahmed El-Balat, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2010
Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complicationsFlorian Heitz, Dejan Ognjenovic, Philipp Harter, et al.
Gynecologic Oncology|January 28, 2014
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancerPhilipp Harter, Bianca Beutel, Piero F Alesina, et al.
Pageof 28